AAIS
CVS icon

ABN AMRO Investment Solutions’s CVS Health CVS Stock Holding History

ABN AMRO Investment Solutions’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.89M Buy
95,603
+33,358
+54% +$2.98M 0.09% 158
2026
Q1 		$4.47M Buy
62,245
+2,681
+5% +$207K 0.06% 213
2025
Q4 		$4.73M Buy
59,564
+48,461
+436% +$3.82M 0.07% 203
2025
Q3 		$837K Sell
11,103
-1,801
-14% -$123K 0.02% 307
2025
Q2 		$890K Hold
12,904
– – 0.02% 305
2025
Q1 		$874K Sell
12,904
-3,434
-21% -$206K 0.02% 298
2024
Q4 		$733K Sell
16,338
-25,163
-61% -$1.41M 0.01% 320
2024
Q3 		$2.61M Buy
41,501
+1,219
+3% +$71.1K 0.05% 232
2024
Q2 		$2.38M Sell
40,282
-77,283
-66% -$4.83M 0.04% 236
2024
Q1 		$9.38M Sell
117,565
-15,903
-12% -$1.21M 0.16% 111
2023
Q4 		$10.5M Sell
133,468
-12,752
-9% -$908K 0.19% 105
2023
Q3 		$10.2M Buy
146,220
+12,799
+10% +$907K 0.2% 105
2023
Q2 		$9.22M Buy
133,421
+490
+0.4% +$34.9K 0.18% 112
2023
Q1 		$9.88M Buy
+132,931
New +$11.1M 0.2% 110

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

ABN AMRO Investment Solutions's CVS Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its CVS Health (CVS) stake by 54% in Q2 2026, buying an estimated $2.98M and bringing the position to 95,603 shares worth $9.89M. The position accounts for 0.09% of the portfolio, ranked #158.

ABN AMRO Investment Solutions first reported a position in CVS in Q1 2023 and has held it in 14 quarters since. The position peaked at $10.5M in Q4 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • ABN AMRO Investment Solutions held 95,603 shares of CVS Health worth $9.89M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 33,358 CVS Health shares in Q2 2026, an estimated $2.98M.
  • CVS Health made up 0.09% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #158 holding.
  • ABN AMRO Investment Solutions first reported a position in CVS Health in Q1 2023 and has held it in 14 quarters since.
  • ABN AMRO Investment Solutions's CVS Health position peaked at $10.5M in Q4 2023.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.